View drug registration information details.
Items | Registration information |
ID | 1692 |
No | 1692 |
Brand Name | LUCIBET |
Ingredients | BICTEGRAVIR SODIUM 50 MG, EMTRICITABINE 200 MG, TENOFOVIR ALAFENAMIDE 25 MG |
Dosage Form | TABLET |
Primary Packaging | BOTTLE |
Storage | |
Shelf Life | 2 YEARS |
Pack Size | BOX OF 30'S/BOTTLE |
Dispensing Category | |
ATC Classification | |
Pharmaceutical Class | |
Indications | AS A COMPLETE REGIMEN FOR THE TREATMENTOF HIV-1 INFECTION IN ADULT AND PEDIATRIC PATIENTS WIEGHING AT LEAST 14 KG |
Contraindications | |
Side Effects | |
Unit Price | |
EDL |
NULL |
Description | DARK RED COLORED, ROUND TABLETS, LETTER LUCIUS ON ONE SIDE AND PLAIN ON THE OTHER |
Note | |
License Owner | LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
Manufacturer | LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
Country | LAOS |
Import Registration No | |
Import Registration Date | |
Activity | CERTIFICATE RELEASED |
Applied Date | |
FDD Registration No | 01 L 1291/25 |
FDD Registration Date | 03-FEB-2025 |
Expiry Date | 02-FEB-2030 |
Back to drug list
|